Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis.

OBJECTIVE The aim of the study was to examine the validity and reliability of a quantifiable measure of inflammation using magnetic resonance imaging (MRI) in children with juvenile dermatomyositis (JDM). METHODS Children with active JDM, inactive JDM and healthy children received detailed assessments of recognized measures of muscle inflammation including muscle strength (manual muscle testing and myometry) and function (Childhood Myositis Assessment Scale, Childhood Health Assessment Questionnaire), the muscle enzymes lactate dehydrogenase (LDH) and creatine kinase (CK) and T2-weighted MRI scans of the thigh muscles, and these values were correlated with each other. RESULTS Ten children with active JDM, 10 with inactive JDM and 20 healthy children completed the study. There was no significant difference in ages between the three groups. The MRI T2 relaxation times were significantly increased in active JDM compared with inactive JDM and healthy children (P = 0.05), indicating a detectable increase in inflammation within the muscles. There were also good correlations between the MRI scores and the measures of muscle strength and function; however, there was no correlation between the MRI and muscle enzymes. CONCLUSIONS The MRI T2 relaxation time can be used as a quantitative measure of muscle inflammation and it has good correlations with other measures of disease activity.

[1]  T. Southwood,et al.  Rapid changes in magnetic resonance imaging of muscle during the treatment of juvenile dermatomyositis. , 1994, British journal of rheumatology.

[2]  C. Partain,et al.  Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. , 1994, Arthritis and rheumatism.

[3]  D. Disler,et al.  Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.

[4]  A. Ashburn,et al.  Use of myometry in the assessment of neuropathic weakness: testing for reliability in clinical practice , 1993 .

[5]  L. Pachman An update on juvenile dermatomyositis , 1995, Current opinion in rheumatology.

[6]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975 .

[7]  J. Malley,et al.  Juvenile idiopathic inflammatory myopathy: exercise-induced changes in muscle at short inversion time inversion-recovery MR imaging. , 1998, Radiology.

[8]  A. Kimball,et al.  Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy. , 2000, Arthritis and rheumatism.

[9]  D. Symmons,et al.  The incidence of juvenile dermatomyositis: results from a nation-wide study. , 1995, British journal of rheumatology.

[10]  D. Isenberg,et al.  Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. , 2001, Rheumatology.

[11]  C. Partain,et al.  Dermatomyositis: correlative MR imaging and P-31 MR spectroscopy for quantitative characterization of inflammatory disease. , 1990, Radiology.

[12]  R. Petty,et al.  Textbook of pediatric rheumatology , 1982 .

[13]  A. Aisen,et al.  Fat-suppressed MR imaging of myositis. , 1992, Radiology.

[14]  T. Chenevert,et al.  MR imaging in children with dermatomyositis: musculoskeletal findings and correlation with clinical and laboratory findings. , 1993, AJR. American journal of roentgenology.

[15]  D. Pongratz,et al.  Magnetic resonance imaging of skeletal muscles in idiopathic inflammatory myopathies of adults , 1994, Journal of Neurology.

[16]  E. Silverman,et al.  Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire. , 1995, The Journal of rheumatology.

[17]  G. Cawkwell,et al.  Inflammatory myositis in children, including differential diagnosis. , 2000, Current opinion in rheumatology.

[18]  L. Pachman,et al.  Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. , 1999, Arthritis and rheumatism.

[19]  A Connelly,et al.  Detection of hippocampal pathology in intractable partial epilepsy , 1993, Neurology.

[20]  J P Miller,et al.  Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy. , 1992, Physical therapy.

[21]  K. Seelos,et al.  Patient monitoring and safety during MRI examinations , 1995, European Radiology.

[22]  H. Lederman,et al.  Juvenile idiopathic inflammatory myopathies: the value of magnetic resonance imaging in the detection of muscle involvement. , 2000, Sao Paulo medical journal = Revista paulista de medicina.